By month 6, the prevalence of viremia was significantly reduced in the LOW vs STD intervention group (6
Hexosaminidase, Beta 0 CommentsBy month 6, the prevalence of viremia was significantly reduced in the LOW vs STD intervention group (6.4% vs 16.3%; em P /em ?=?.028), whereas use of an ACEi/ARB had no effect on prevalence of viremia. group as a single dosage of 0.15\0.20?mg/kg, with dosage adjustments as had a need to achieve the mark trough